Diseases, Conditions, Syndromes

Omicron now dominant in EU: health agency

Omicron is now the dominant COVID-19 variant circulating in the European Union and European Economic Area (EAA), the bloc's health agency said on Friday.


More than 2 dozen drugmakers to make Merck's COVID-19 pill

A U.N.-backed organization announced Thursday that it has signed agreements with more than two dozen generic drug makers to produce versions of Merck's COVID-19 pill to supply 105 developing countries.

Diseases, Conditions, Syndromes

Pfizer/BioNTech to develop mRNA-based shingles shot

Germany's BioNTech and US pharma giant Pfizer, which together developed a COVID-19 vaccine in record time, said Wednesday they are working on a shingles shot using the same mRNA technology.

Diseases, Conditions, Syndromes

Low-vaccinated Eastern Europe braces for omicron surge

As the fast-spreading coronavirus variant omicron rages through Western Europe, officials and experts in low-vaccinated Eastern Europe anticipate a post-holiday explosion of COVID-19 cases in much of the region.

Diseases, Conditions, Syndromes

Germany sees omicron dominant soon, pushes on vaccination

The omicron variant could be dominant in Germany in one to three weeks, a senior official said Wednesday, while the health minister called for vaccination centers to be kept open over the Christmas holidays to keep the country's ...


EU authorises Novavax as fifth COVID vaccine

The European Commission on Monday authorised a vaccine from US company Novavax as its fifth official jab for use across the European Union, hours after the EU medicines watchdog gave approval.


EU set to back Novavax COVID vaccine

The EU's drug regulator will decide Monday whether to approve a COVID jab by Novavax, which uses a more conventional technology that the US biotech firm hopes will reduce vaccine hesitancy.

page 4 from 40